Endocrinology / diabetes clinical trials recruiting in Pennsylvania

294 recruiting endocrinology / diabetes trials match in Pennsylvania. Showing 20.

• ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsRecruiting

  Phase 1 / Phase 2 · Immatics US, Inc. · Philadelphia, Pennsylvania

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)Recruiting

  Phase 3 · AstraZeneca · Gettysburg, Pennsylvania

• Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaRecruiting

  Phase 2 · National Cancer Institute (NCI) · Beaver, Pennsylvania

• FTT PET/CT in Pancreatic Neuroendocrine TumorsRecruiting

  Phase 1 · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania

• An Acceptance-Based Healthy Lifestyle Intervention for Diverse AdolescentsRecruiting

  N/A · Drexel University · Philadelphia, Pennsylvania

• Feasibility of Semaglutide in Advanced Lung DiseaseRecruiting

  Phase 1 / Phase 2 · University of Pennsylvania · Philadelphia, Pennsylvania

• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideRecruiting

  Phase 2 · Eli Lilly and Company · Scottdale, Pennsylvania

• Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 StudyRecruiting

  N/A · M.D. Anderson Cancer Center · Philadelphia, Pennsylvania

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Pittsburgh, Pennsylvania

• Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationRecruiting

  Phase 1 · Senhwa Biosciences, Inc. · Pittsburgh, Pennsylvania

• Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)Recruiting

  N/A · Jaeb Center for Health Research · Philadelphia, Pennsylvania

• Study of CP-383 in Patients With Advanced or Metastatic Solid TumorsRecruiting

  Phase 1 / Phase 2 · Tasca Therapeutics · Philadelphia, Pennsylvania

• CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian CancerRecruiting

  Phase 1 · Lan Coffman · Pittsburgh, Pennsylvania

• Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)Recruiting

  Phase 3 · Genelux Corporation · Pittsburgh, Pennsylvania

• Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaRecruiting

  Phase 3 · Immuneering Corporation · Philadelphia, Pennsylvania

• Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN TrialsRecruiting

  N/A · Eastern Cooperative Oncology Group · Bristol, Tennessee

• Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TCRecruiting

  Phase 2 · Massachusetts General Hospital · Philadelphia, Pennsylvania

• Resilience to the Effects of Advertising in ChildrenRecruiting

  N/A · Penn State University · University Park, Pennsylvania

• Pancreatic Cancer Detection Consortium (PCDC) Prospective CohortsRecruiting

  N/A · Mayo Clinic · Pittsburgh, Pennsylvania

• Phenotyping Genetic Risk for Type 2 DiabetesRecruiting

  N/A · University of Pennsylvania · Philadelphia, Pennsylvania

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.